Project ECHO can be used to improve access to care in rural and underserved areas by sharing knowledge, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Project ECHO can be used to improve access to care in rural and underserved areas by sharing knowledge, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Transcript
What are some of the impacts of Project ECHO?
If a patient wants treatment, they can get treatment anywhere in New Mexico, and even in 2003 when I started Project ECHO, it was not a shortage of medicines—the medicines were available for every patient that I had—it was a shortage of knowledge. But now we have the right knowledge at the right place at that right time, and people can get access to treatment and the cure rates are very high and access is really good for hepatitis C.
Now, my dream is that I can have the same kind of access for many, many other health conditions, including cancer. So, for example, there is now a lot of evidence that patients in rural areas have higher mortality from cancer. We also know that African American women have the same mortality from breast cancer in the ‘70s as white women. Now, African American women die—43% more likely to die from breast cancer if they have it than white women. So, we want to reduce this disparity, because right now it’s very difficult to get best-practice care to underserved areas, to rural areas, because the right experts are not there. The right knowledge is not there.
The Challenge of Addressing Drug Spend to Drive Down Total Cost of Care in EOM
October 27th 2024Stuart Staggs, vice president of transformation and shared services at McKesson, explained that oncology practices in the Enhancing Oncology Model (EOM) have a tough job driving down costs when drug costs make up a larger portion of the total cost of care.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Targeting Progression: Amivantamab’s Role in NSCLC After Osimertinib
October 24th 2024Amivantamab's role in non–small cell lung cancer (NSCLC) has been a highlight of the lung cancer space this year, with the 2 most recent approvals based on data from the MARIPOSA and MARIPOSA-2 trials.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More